Sermorelin vs CJC-1295 + Ipamorelin: What’s the Difference?
Sermorelin and CJC-1295 + Ipamorelin are commonly discussed in hormone optimization and healthy aging conversations, but they are not the same.
Growth Hormone Signaling Basics
Peptides in this category are often discussed for growth hormone signaling, recovery, sleep quality, and body composition. Learn more on Omni’s hormone optimization peptide page.
The right option depends on your health history, lab work when appropriate, and goals.
What Is Sermorelin?
Sermorelin is a growth hormone releasing hormone analog frequently discussed for sleep, recovery, body composition, and healthy aging.
It is commonly explored by patients interested in supporting natural signaling pathways.
What Is CJC-1295 + Ipamorelin?
CJC-1295 + Ipamorelin is a combination often discussed for growth hormone axis support, recovery, body composition, and sleep.
Dr. Lauren Peizer, ND can help determine which approach may be appropriate.
Want to Know Which Peptide Protocol May Be Right For You?
Meet with Dr. Lauren Peizer, ND at Omni Centers to discuss your symptoms, goals, health history, and whether peptide therapy may be appropriate.
SCHEDULE CONSULTATIONHelpful Peptide Therapy Pages
Related Internal Links
Frequently Asked Questions
Is Sermorelin the same as CJC-1295 + Ipamorelin?
No. They are different peptide approaches commonly discussed for growth hormone signaling and healthy aging.
Which one is better?
The better option depends on your goals, symptoms, lab work when appropriate, and provider recommendations.
Can these be used for hormone optimization?
They are commonly discussed in hormone optimization and healthy aging conversations.
Schedule Your Peptide Therapy Consultation
Call 360.338.0289 or book online to begin your personalized consultation at Omni Centers.
BOOK CONSULTATIONDisclaimer: This information is for educational purposes only and does not constitute medical advice. Peptide therapies should only be initiated under the care of a licensed medical provider following an appropriate evaluation. Individual results vary. Some peptides may be compounded and prescribed based on individual clinical indication; others may be FDA-approved for specific uses. Availability is subject to regulatory status, pharmacy availability, and provider determination.
